- Market Realist•4 days ago
Vertex Pharmaceuticals (VRTX) will report its 2Q16 earnings on July 27, 2016. Based in Boston, VRTX is a global biotechnology company that primarily focuses on cystic fibrosis drugs.
- Barrons.com•4 days ago
Stocks like Valeant Pharmaceuticals International (VRX), Mallinckrodt (MNK), Endo International (ENDP), and Allergan (AGN) have been hit hard this year by concerns about how their drugs are priced. Guggenheim analyst Louise Chen and team, however, argue that the drug-pricing overhang could be on its way out. The Medicare Part B Demo received 1,300 comments demonstrating how controversial any changes to drug pricing could be...In our coverage universe, the high priced drug debate has weighed on Allergan, Shire (SHPG), Valeant Pharmaceuticals International, Endo International, Mallinckrodt and Jazz Pharmaceuticals (JAZZ).
Pre-Market: 193.06-0.43 (-0.22%) as of 6:22 AM EDT
|Bid||193.13 x 500|
|Ask||193.27 x 800|
|52wk Range||147.60 - 270.63|
|Day's Range||191.62 - 193.86|
|Avg Vol (3m)||2,882,282|
As of 4:00 PM EDT. Market closed.